HK Stock MarketDetailed Quotes

02162 KEYMED BIO-B

Watchlist

44.150
-0.850-1.89%

Trading Mar 31 13:11 CST

12.35BMarket Cap-22.20P/E (TTM)

KEYMED BIO-B Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Turnover

20.91%428.12M

-83.28%54.68M

253.87%354.1M

227.12%327.12M

-9.26%100.06M

--100M

--110.27M

----

Operating income

20.91%428.12M

-83.28%54.68M

253.87%354.1M

227.12%327.12M

-9.26%100.06M

100M

110.27M

Cost of sales

66.92%-12.2M

75.12%-3.74M

-1,326.62%-36.88M

-491.92%-15.02M

84.97%-2.59M

---2.54M

---17.2M

----

Operating expenses

66.92%-12.2M

75.12%-3.74M

-1,326.62%-36.88M

-491.92%-15.02M

84.97%-2.59M

-2.54M

-17.2M

Gross profit

31.12%415.92M

-83.68%50.95M

225.42%317.22M

220.23%312.11M

4.74%97.48M

97.46M

93.07M

Selling expenses

---110.9M

---23.25M

----

Administrative expenses

-6.17%-187.93M

-9.20%-89.95M

-32.18%-177.01M

-61.36%-82.37M

-44.84%-133.91M

-90.22%-51.05M

-329.06%-92.45M

---26.84M

-42.16%-21.55M

---15.16M

Research and development expenses

-23.30%-735.19M

-32.54%-331.03M

-17.52%-596.28M

-52.28%-249.76M

-41.66%-507.37M

14.16%-164.01M

-181.13%-358.16M

---191.06M

-96.57%-127.4M

---64.81M

Revaluation surplus

----

-399.70%-3.48B

---3.4B

-616.44%-696.47M

---97.21M

-Changes in the fair value of other assets

----

-399.70%-3.48B

---3.4B

-616.44%-696.47M

---97.21M

Operating interest expense

----

77.97%-1.33M

---11.13M

---6.04M

----

Special items of operating profit

9.25%133.17M

-7.90%73.31M

-52.81%121.89M

-38.89%79.6M

701.51%258.32M

518.93%130.26M

-205.05%-42.95M

--21.05M

166.36%40.88M

--15.35M

Operating profit

-45.11%-484.93M

-637.05%-319.96M

-17.06%-334.18M

425.61%59.58M

92.66%-285.49M

100.31%11.34M

-383.74%-3.89B

-3.6B

-397.14%-804.54M

-161.84M

Financing cost

-6.96%-18.46M

5.07%-8.86M

-105.54%-17.26M

---9.34M

---8.4M

----

-152.05%-14.31M

---5.68M

Share of profit from joint venture company

-10.70%-5.26M

19.03%-1.7M

51.11%-4.75M

76.20%-2.1M

-1,250.63%-9.71M

---8.81M

---719K

----

Special items of earning before tax

----

---27.75M

----

Earning before tax

-42.80%-508.65M

-786.52%-330.52M

-17.32%-356.19M

1,807.49%48.15M

92.20%-303.6M

100.07%2.52M

-375.38%-3.89B

-3.63B

-388.83%-818.85M

-167.51M

Tax

-291.98%-6.26M

---6.08M

---1.6M

----

After-tax profit from continuing operations

-43.92%-514.91M

-799.14%-336.6M

-17.85%-357.79M

1,807.49%48.15M

92.20%-303.6M

100.07%2.52M

-375.38%-3.89B

-3.63B

-388.83%-818.85M

-167.51M

Earning after tax

-43.92%-514.91M

-799.14%-336.6M

-17.85%-357.79M

1,807.49%48.15M

92.20%-303.6M

100.07%2.52M

-375.38%-3.89B

-3.63B

-388.83%-818.85M

-167.51M

Minority profit

-78.75%334K

-87.95%142K

-65.21%1.57M

140.20%1.18M

184.88%4.52M

-51.73%-2.93M

-1,908.68%-5.32M

---1.93M

---265K

----

Profit attributable to shareholders

-43.38%-515.24M

-816.98%-336.75M

-16.63%-359.36M

761.15%46.97M

92.07%-308.12M

100.15%5.45M

-374.88%-3.89B

-3.63B

-388.67%-818.58M

-167.51M

Basic earnings per share

-43.80%-1.97

-816.67%-1.29

-16.10%-1.37

765.38%0.18

95.12%-1.18

100.04%0.0208

-98.11%-24.17

-54.08

-12.2

Diluted earnings per share

-43.80%-1.97

-816.67%-1.29

-16.10%-1.37

782.35%0.18

95.12%-1.18

100.04%0.0204

-98.11%-24.17

-54.08

-12.2

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Turnover	20.91%428.12M	-83.28%54.68M	253.87%354.1M	227.12%327.12M	-9.26%100.06M	--100M	--110.27M	----	----	----
Operating income	20.91%428.12M	-83.28%54.68M	253.87%354.1M	227.12%327.12M	-9.26%100.06M	100M	110.27M
Cost of sales	66.92%-12.2M	75.12%-3.74M	-1,326.62%-36.88M	-491.92%-15.02M	84.97%-2.59M	---2.54M	---17.2M	----	----	----
Operating expenses	66.92%-12.2M	75.12%-3.74M	-1,326.62%-36.88M	-491.92%-15.02M	84.97%-2.59M	-2.54M	-17.2M
Gross profit	31.12%415.92M	-83.68%50.95M	225.42%317.22M	220.23%312.11M	4.74%97.48M	97.46M	93.07M
Selling expenses	---110.9M	---23.25M	----	----	----	----	----	----	----	----
Administrative expenses	-6.17%-187.93M	-9.20%-89.95M	-32.18%-177.01M	-61.36%-82.37M	-44.84%-133.91M	-90.22%-51.05M	-329.06%-92.45M	---26.84M	-42.16%-21.55M	---15.16M
Research and development expenses	-23.30%-735.19M	-32.54%-331.03M	-17.52%-596.28M	-52.28%-249.76M	-41.66%-507.37M	14.16%-164.01M	-181.13%-358.16M	---191.06M	-96.57%-127.4M	---64.81M
Revaluation surplus	----	----	----	----	----	----	-399.70%-3.48B	---3.4B	-616.44%-696.47M	---97.21M
-Changes in the fair value of other assets	----	----	----	----	----	----	-399.70%-3.48B	---3.4B	-616.44%-696.47M	---97.21M
Operating interest expense	----	----	----	----	----	77.97%-1.33M	---11.13M	---6.04M	----	----
Special items of operating profit	9.25%133.17M	-7.90%73.31M	-52.81%121.89M	-38.89%79.6M	701.51%258.32M	518.93%130.26M	-205.05%-42.95M	--21.05M	166.36%40.88M	--15.35M
Operating profit	-45.11%-484.93M	-637.05%-319.96M	-17.06%-334.18M	425.61%59.58M	92.66%-285.49M	100.31%11.34M	-383.74%-3.89B	-3.6B	-397.14%-804.54M	-161.84M
Financing cost	-6.96%-18.46M	5.07%-8.86M	-105.54%-17.26M	---9.34M	---8.4M	----	----	----	-152.05%-14.31M	---5.68M
Share of profit from joint venture company	-10.70%-5.26M	19.03%-1.7M	51.11%-4.75M	76.20%-2.1M	-1,250.63%-9.71M	---8.81M	---719K	----	----	----
Special items of earning before tax	----	----	----	----	----	----	----	---27.75M	----	----
Earning before tax	-42.80%-508.65M	-786.52%-330.52M	-17.32%-356.19M	1,807.49%48.15M	92.20%-303.6M	100.07%2.52M	-375.38%-3.89B	-3.63B	-388.83%-818.85M	-167.51M
Tax	-291.98%-6.26M	---6.08M	---1.6M	----	----	----	----	----	----	----
After-tax profit from continuing operations	-43.92%-514.91M	-799.14%-336.6M	-17.85%-357.79M	1,807.49%48.15M	92.20%-303.6M	100.07%2.52M	-375.38%-3.89B	-3.63B	-388.83%-818.85M	-167.51M
Earning after tax	-43.92%-514.91M	-799.14%-336.6M	-17.85%-357.79M	1,807.49%48.15M	92.20%-303.6M	100.07%2.52M	-375.38%-3.89B	-3.63B	-388.83%-818.85M	-167.51M
Minority profit	-78.75%334K	-87.95%142K	-65.21%1.57M	140.20%1.18M	184.88%4.52M	-51.73%-2.93M	-1,908.68%-5.32M	---1.93M	---265K	----
Profit attributable to shareholders	-43.38%-515.24M	-816.98%-336.75M	-16.63%-359.36M	761.15%46.97M	92.07%-308.12M	100.15%5.45M	-374.88%-3.89B	-3.63B	-388.67%-818.58M	-167.51M
Basic earnings per share	-43.80%-1.97	-816.67%-1.29	-16.10%-1.37	765.38%0.18	95.12%-1.18	100.04%0.0208	-98.11%-24.17	-54.08	-12.2
Diluted earnings per share	-43.80%-1.97	-816.67%-1.29	-16.10%-1.37	782.35%0.18	95.12%-1.18	100.04%0.0204	-98.11%-24.17	-54.08	-12.2
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion
Auditor	--	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights